NEW HAVEN, Conn., April 08, 2020 (GLOBE NEWSWIRE) — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization […]
Enrollment in PRISM Study Progressing – Sample Size Re-estimation Planned for mid-2020 Expect to Report Top-Line Data in both PN
Investment in automation and industrial technology for the fenestration industry Wilton, CT, March 9, 2020 – Altus Capital Partners, an
Seasoned biopharmaceutical executive with over 30 years of drug development experience New Haven, Conn., February 18, 2020 – Trevi Therapeutics, Inc.
Driven by aging infrastructure, US utilities are making significant investments to replace and upgrade as well as expand new and
Acquisition adds production capacity, engineering support, product breadth, and operations leadership expertise to existing capabilities Nashville, TN, January 9, 2020
